Does addition of Tazarotene cream help in controlling fungal infections of skin over and above two antifungal medicines?
Phase 4
- Conditions
- Health Condition 1: B354- Tinea corporis
- Registration Number
- CTRI/2019/09/021049
- Lead Sponsor
- Bankura Sammilani Medical Collge
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Untreated male and non-¬pregnant female patients above 18 years of age;
Acute, symptomatic tinea cruris/corporis with limited involvement i.e. limited to single body region;
KOH mount showing positive results (hyphae)
Exclusion Criteria
Pregnant or nursing females;
Patients with diabetes mellitus, malignancy, renal or hepatic dysfunction;
Patients who received topical antifungal agents within the past week or received systemic antifungal agents within past four weeks;
History of hypersensitivity to any of the study drugs;
Patients not willing to comply with protocol requirements
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 100% Clinical cure (Disappearance of original lesions with or without residual pigmentation)Timepoint: 4th week and 6th week
- Secondary Outcome Measures
Name Time Method